Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „majority“
Suchtreffer
Begriffe & Kennungen
Adcetris · 4.8 · In patients with relapsed or refractory HL or sALCL who were retreated with ADCETRIS (SGN35-006), the majority
Eintrag öffnenAldurazyme · 4.8 · Summary of the safety profile The majority of the related adverse events in the clinical trials were classifie
Eintrag öffnenAlli (previously Orlistat GSK) · 4.5 · The vast majority of subjects receiving up to 4 full years of treatment with orlistat in clinical studies had
Eintrag öffnenAzacitidine Mylan · 4.8 · Skin and subcutaneous tissue adverse reactions The majority of skin and subcutaneous adverse reactions were as
Eintrag öffnenBenlysta · 4.8 · 31 The majority of patients were also receiving one or more of the following concomitant treatments for SLE: c
Eintrag öffnenBenlysta · 4.8 · 7 The majority of patients were also receiving one or more of the following concomitant treatments for SLE: co
Eintrag öffnenBenlysta · 4.8 · The majority of patients were also receiving one or more of the following concomitant treatments for SLE: cort
Eintrag öffnenBeyfortus · 4.8 · The most frequent adverse reaction was rash (0.7%) occurring within 14 days post dose. The majority of cases w
Eintrag öffnenBeyonttra · 4.8 · The majority of events of diarrhoea and gout were non-serious and resolved.
Eintrag öffnenBimzelx · 4.8 · The majority of infections consisted of non-serious mild to moderate upper respiratory tract infections such a
Eintrag öffnenBlincyto · 4.8 · The observed time to onset of ICANS ranged from 0 to 299 days with the majority of ICANS occurring within the
Eintrag öffnenByooviz · 4.8 · 6 The majority of adverse reactions reported following administration of ranibizumab are related to the intrav
Eintrag öffnenByooviz · 4.8 · The majority of adverse reactions reported following administration of ranibizumab are related to the intravit
Eintrag öffnenCatiolanze · 4.8 · The majority of adverse reactions relate to the ocular system. In an open 5-year safety study with preserved l
Eintrag öffnenColumvi · 4.8 · The observed time to onset of the majority of ICANS was 1-7 days with median of 2 days after the most recent d
Eintrag öffnenCombivir · 4.5 · Methadone dosage adjustment unlikely in majority of patients; occasionally methadone re-titration may be requi
Eintrag öffnenConbriza · 4.8 · The majority of adverse reactions occurring during the clinical trials were mild to moderate in severity and d
Eintrag öffnenCotellic · 4.8 · The majority of events were Grade 1 or 2 and non-serious. Most events resolved with no change in Cotellic dose
Eintrag öffnenDarzalex · 4.8 · Cardiac disorders and AL amyloidosis-related cardiomyopathy The majority of patients in AMY3001 had AL amyloid
Eintrag öffnenElaprase · 4.8 · All patients with the complete deletion/large rearrangement genotype developed antibodies, and the majority of
Eintrag öffnen